tradingkey.logo

Gelteq Ltd

GELS

1.690USD

+0.070+4.32%
Horarios del mercado ETCotizaciones retrasadas 15 min
16.31MCap. mercado
PérdidaP/E TTM

Gelteq Ltd

1.690

+0.070+4.32%
Más Datos de Gelteq Ltd Compañía
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Información de la empresa
Símbolo de cotizaciónGELS
Nombre de la empresaGelteq Ltd
Fecha de salida a bolsaOct 29, 2024
Director ejecutivoMr. Nathan Jacob Givoni
Número de empleados7
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 29
DirecciónLevel 4
CiudadMELBOURNE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísAustralia
Código postal3205
Teléfono61390873990
Sitio Webhttps://www.gelteq.com
Símbolo de cotizaciónGELS
Fecha de salida a bolsaOct 29, 2024
Director ejecutivoMr. Nathan Jacob Givoni
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Markoff (Jeffrey)
25.86%
Golik (David)
10.73%
Givoni (Nathan Jacob)
6.96%
Crestmont Pty Ltd
6.81%
Barabash Family Trust
4.67%
Other
44.97%
Accionistas
Accionistas
Proporción
Markoff (Jeffrey)
25.86%
Golik (David)
10.73%
Givoni (Nathan Jacob)
6.96%
Crestmont Pty Ltd
6.81%
Barabash Family Trust
4.67%
Other
44.97%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
48.88%
Corporation
11.48%
Research Firm
0.59%
Hedge Fund
0.27%
Investment Advisor
0.25%
Other
38.53%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
15
5.80M
61.47%
+24.19K
2025Q1
15
5.80M
61.47%
+24.19K
2024Q4
13
5.78M
61.21%
+80.95K
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Markoff (Jeffrey)
2.44M
25.86%
--
--
Nov 15, 2024
Golik (David)
1.01M
10.73%
--
--
Nov 15, 2024
Givoni (Nathan Jacob)
657.09K
6.96%
--
--
Nov 15, 2024
Crestmont Pty Ltd
642.32K
6.81%
--
--
Nov 15, 2024
Barabash Family Trust
441.00K
4.67%
--
--
Nov 15, 2024
Szewach (Simon Hayden)
338.20K
3.58%
--
--
Nov 15, 2024
Olyniec (Jeffrey W.)
164.81K
1.75%
--
--
Nov 15, 2024
Wedbush Securities, Inc.
52.25K
0.55%
+1.25K
+2.45%
Mar 31, 2025
UBS Financial Services, Inc.
23.45K
0.25%
+17.25K
+278.35%
Mar 31, 2025
Citadel Advisors LLC
15.16K
0.16%
-8.58K
-36.14%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI